Skip to main content

Table 3 MiR-182-5p expression in LUAD from miRNA-seq data

From: MiR-182-5p and its target HOXA9 in non-small cell lung cancer: a clinical and in-silico exploration with the combination of RT-qPCR, miRNA-seq and miRNA-chip

Characteristics n Relevant expression of miR-182-5p (log2x)
Mean ± SD t/F-value P-value
Tissue LUAD 448 14.273 ± 0.947 17.368 < 0.001*
Noncancerous 45 11.644 ± 1.160
Gender Male 209 14.259 ± 0.902 −0.306 0.760
Female 239 14.286 ± 0.987
Age(years) ≤50 33 14.295 ± 1.205 0.175 0.862
> 50 396 14.257 ± 0.932
T T1 + T2 388 14.294 ± 0.954 0.679 0.497
T3 + T4 57 14.203 ± 0.871
Nodes No 293 14.252 ± 0.966 −1.025 0.306
Yes 146 14.349 ± 0.892
Metastasis No 285 14.326 ± 0.898 −0.366 0.715
Yes 19 14.404 ± 1.027
Pathologic stage I-II 351 14.249 ± 0.958 −0.810 0.419
III-IV 92 14.340 ± 0.918
Anatomic neoplasm subdivision L-Lower 70 14.229 ± 0.825 0.512a 0.727
L-Upper 108 14.206 ± 0.998
R-Lower 85 14.214 ± 0.940
R-Middle 18 14.281 ± 0.789
R-Uppr 155 14.351 ± 0.986
Tumor location Peripheral 113 14.309 ± 0.940 −0.743 0.459
Central 54 14.429 ± 1.051
  1. LUAD: lung adenocarcinoma; SD: standard deviation
  2. a One-way analysis of variance (ANOVA) was performed
  3. * The results were statistically significant (P < 0.05)